The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Update on phase 1 study of tazemetostat, an enhancer of zeste homolog 2 inhibitor, in pediatric patients with relapsed or refractory integrase interactor 1–negative tumors.
 
Susan N. Chi
Consulting or Advisory Role - Blueprint Medicines; Epizyme
Travel, Accommodations, Expenses - Epizyme
 
Franck Bourdeaut
Consulting or Advisory Role - BMS (Inst)
 
Michela Casanova
Consulting or Advisory Role - AstraZeneca; Bayer; BMS; Roche; Servier
Travel, Accommodations, Expenses - Bayer; Roche
 
Lindsay Baker Kilburn
Employment - Kaiser Permanente (I)
Consulting or Advisory Role - Roche/Genentech
Research Funding - Epizyme (Inst); Novartis (Inst); Regeneron (Inst)
 
Darren R. Hargrave
No Relationships to Disclose
 
Geoffrey Brian McCowage
Consulting or Advisory Role - Biogen (I)
Research Funding - Merck (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - BIOGEN (I)
 
Navin R. Pinto
No Relationships to Disclose
 
Jay Yang
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Raminder Chadha
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Bhaskar Kahali
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Coya Tapia
Employment - Epizyme
Stock and Other Ownership Interests - Epizyme
 
Karsten Nysom
Honoraria - Y-mAbs Therapeutics
Consulting or Advisory Role - Bayer; EUSA Pharma; Ymabs Therapeutics Inc
Travel, Accommodations, Expenses - Bayer